Loại tài liệu:    Chỉ tìm trong: 
11-20 trong số 33 kết quả
Therapeutic Potential of Janus Kinase Inhibitors for Treating Refractory Behçet Disease
Tác giả: Yoshinori Taniguchi, Hirotaka Yamamoto
Xuất bản: United States: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , 2025
Bộ sưu tập: NCBI
ddc:  657.862
 
Pantothenate Kinase 1 (PANK1) Identified as a Direct Target of SGLT2 Inhibitors in the Heart
Tác giả: Ghadir Amin, George W Booz, Fouad A Zouein
Xuất bản: United States: Journal of cardiovascular pharmacology , 2025
Bộ sưu tập: NCBI
ddc:  343.0933
 
Pantothenate Kinase 1 (PANK1) Identified as a Direct Target of SGLT2 Inhibitors in the Heart
Tác giả: Ghadir Amin, George W Booz, Fouad A Zouein
Xuất bản: United States: Journal of cardiovascular pharmacology , 2025
Bộ sưu tập: NCBI
ddc:  439.817009
 
Significance of phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysis
Tác giả: Asma Naqi, Mohammad Ahmed Khan, Abul Kalam Najmi
Xuất bản: Italy: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , 2025
Bộ sưu tập: NCBI
ddc:  698.142
 
Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis
Tác giả: Shyfuddin Ahmed, Ruth M Pfeiffer, Sarah S Jackson, Minkyo Song, Xavier Mariette, Raphaele Seror, Eric A Engels
Xuất bản: England: Rheumatology (Oxford, England , 2025
Bộ sưu tập: NCBI
ddc:  333.822
 
The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling
Tác giả: Darya Zibrova, Thomas Ernst, Andreas Hochhaus, Regine Heller
Xuất bản: Netherlands: Molecular and cellular biochemistry , 2025
Bộ sưu tập: NCBI
ddc:  344.072
 
Recent advances in CDC7 kinase inhibitors: Novel strategies for the treatment of cancers and neurodegenerative diseases
Tác giả: Xi Peng, Wentao Tang, Yu Jiang, Anjiao Peng, Yao Xiao, Yiwen Zhang
Xuất bản: France: European journal of medicinal chemistry , 2025
Bộ sưu tập: NCBI
ddc:  620.004
 
Carboxamide Spleen Tyrosine Kinase (Syk) Inhibitors [electronic resource] : Leveraging Ground State Interactions To Accelerate Optimization
Tác giả:
Xuất bản: Argonne, Ill. : Oak Ridge, Tenn: Argonne National Laboratory ; Distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy , 2016
Bộ sưu tập: Báo, Tạp chí
ddc:  547.2
 
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional
Tác giả: Yuji Uehara, Hiroki Izumi, Shuhei Teranishi, Shingo Miyamoto, Masahide Mori, Chiho Nakashima, Shuichi Asano, Hajime Oi, Tetsuya Sakai, Yuji Shibata, Hibiki Udagawa, Eri Sugiyama, Ikei S Kobayashi, Kaname Nosaki, Shigeki Umemura, Yoshitaka Zenke, Kiyotaka Yoh, Sadakatsu Ikeda, Daniel B Costa, Susumu S Kobayashi, Koichi Goto, Shingo Matsumoto, Yukio Hosomi, Takae Okuno, Jun Sugisaka, Naoto Takase, Kageaki Taima, Shinichi Sasaki
Xuất bản: Ireland: Lung cancer (Amsterdam, Netherlands , 2025
Bộ sưu tập: NCBI
ddc:  595.798
 
Targeting Anaplastic Lymphoma Kinase in Oncology: Identification and Computational Validation of Novel Inhibitors for Anaplastic Large Cell Lymphoma, Non-small Cell Lung Cancer, and Neuroblastoma
Tác giả: Aftab Alam, Mohammed H Alqarni, Indrakant K Singh, Ahmed I Foudah, Neeraj Upmanyu, Mohamed F Balaha
Xuất bản: United Arab Emirates: Current pharmaceutical design , 2025
Bộ sưu tập: NCBI
ddc:  616.856
 

Truy cập nhanh danh mục